van Dongen, J. E. & Segerink, L. I. Building the future of clinical diagnostics: an analysis of potential benefits and current barriers in CRISPR/Cas diagnostics. ACS Synth. Biol. 14, 323–331 (2025).
Lubbers, B. R. et al. The new EU regulation on in vitro diagnostic medical devices: Implications and preparatory actions for diagnostic laboratories. HemaSphere 5, e568 (2021).
Kaminski, M. M., Abudayyeh, O. O., Gootenberg, J. S., Zhang, F. & Collins, J. J. CRISPR-based diagnostics. Nat. Biomed. Eng. 5, 643–656 (2021).
Hu, T. & Chen, X. Nano for CRISPR. ACS Nano 16, 8505–8506 (2022).
Chowdhry, R. et al. Enhancing CRISPR/Cas systems with nanotechnology. Trends Biotechnol. 41, 1549–1564 (2023).
Yu, E. S. et al. Highly efficient on-chip photothermal cell lysis for nucleic acid extraction using localized plasmonic heating of strongly absorbing Au nanoislands. ACS Appl. Mater. Interfaces 15, 34323–34331 (2023).
Marcuccio, F. et al. Single-cell nanobiopsy enables multigenerational longitudinal transcriptomics of cancer cells. Sci. Adv. 10, 515 (2024).
Yang, B., Kong, J. & Fang, X. Programmable CRISPR-Cas9 microneedle patch for long-term capture and real-time monitoring of universal cell-free DNA. Nat. Commun. 13, 3999 (2022).
Jeong, S. et al. Extraction of viral nucleic acids with carbon nanotubes increases SARS-CoV-2 quantitative reverse transcription polymerase chain reaction detection sensitivity. ACS Nano 15, 10309–10317 (2021). This study proposed high-yield capture of viral RNA from 50% human saliva using ssDNA attached to carbon nanotubes, thereby bypassing commercial kits and biofluid purification steps.
Bogers, J. F. M. et al. Bright fluorescent nucleic acid detection with CRISPR-Cas12a and poly(thymine) templated copper nanoparticles. Biol. Methods Protoc. 6, bpaa020 (2021).
Song, J. et al. Elution-free DNA detection using CRISPR/Cas9-mediated light-up aptamer transcription: toward all-in-one DNA purification and detection tube. Biosens. Bioelectron. 225, 115085 (2023).
Zhou, W. et al. A CRISPR–Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection. Nat. Commun. 9, 5012 (2018).
Mohsenin, H. et al. Signal-amplifying biohybrid material circuits for CRISPR/Cas-based single-stranded RNA detection. Adv. Mater. Technol. 10, 2400981 (2024).
Zhang, S., Xu, D., Li, F. & Wang, J. CRISPR-based non-nucleic acid detection. Trends Biotechnol. (2025).
Liu, Z. et al. Determination of adenosine by CRISPR-Cas12a system based on duplexed aptamer and molecular beacon reporter linked to gold nanoparticles. Microchim. Acta 190, 173 (2023).
Zhang, Q. et al. Controllable assembly of a quantum dot-based aptasensor guided by CRISPR/Cas12a for direct measurement of circulating tumor cells in human blood. Nano Lett. 24, 2360–2368 (2024).
Chen, Y. et al. Applying CRISPR/Cas system as a signal enhancer for DNAzyme-based lead ion detection. Anal. Chim. Acta (2021).
Wu, Z., Sun, D. W., Pu, H. & Wei, Q. A novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1. Talanta 252, 123773 (2023).
Hao, L. et al. CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics. Nat. Nanotechnol. 18, 798–807 (2023). This study presented a non-invasive, multiplexed approach for cancer detection and monitoring, combining peptide-conjugated synthetic or biological nanocarriers with a novel DNA barcoding system.
Pandit, S., Duchow, M., Chao, W., Capasso, A. & Samanta, D. DNA-barcoded plasmonic nanostructures for activity-based protease sensing. Angew. Chem. Int. Ed. 63, e202310964 (2024).
Welch, N. L. et al. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants. Nat. Med. 28, 1083–1094 (2022). This study proposed a highly multiplexed microfluidic platform for the rapid detection of SARS-CoV-2 variants with a classification accuracy comparable to sequencing.
Tian, T. et al. An ultralocalized Cas13a assay enables universal and nucleic acid amplification-free single-molecule RNA diagnostics. ACS Nano 15, 1167–1178 (2021).
Chen, J. et al. CRISPR-powered optothermal nanotweezers: diverse bio-nanoparticle manipulation and single nucleotide identification. Light. Sci. Appl. 12, 273 (2023).
Yuan, A. et al. RNA-activated CRISPR/Cas12a nanorobots operating in living cells. J. Am. Chem. Soc. (2024). This study presented Cas12a-based nanorobots for the real-time detection of microRNAs in living cells, paving the way for advanced intracellular monitoring and therapeutic applications.
Yuan, C. et al. Universal and naked-eye gene detection platform based on the clustered regularly interspaced short palindromic repeats/Cas12a/13a system. Anal. Chem. 92, 4029–4037 (2020).
López-Valls, M. et al. CASCADE: naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles. Anal. Chim. Acta 1205, 339749 (2022).
Broughton, J. P. et al. CRISPR–Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. (2020).
MacGregor, S. R. et al. Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis. EBioMedicine 94, 104730 (2023).
Zhang, X., Yang, Y., Cao, J., Qi, Z. & Li, G. Point‐of‐care CRISPR/Cas biosensing technology: a promising tool for preventing the possible COVID‐19 resurgence caused by contaminated cold‐chain food and packaging. Food Front. 4, 207–232 (2023).
Moon, J. et al. Colorimetric detection of SARS-CoV-2 and drug-resistant pH1N1 using CRISPR/dCas9. ACS Sens. 5, 4017–4026 (2020).
Samanta, D., Ebrahimi, S. B., Ramani, N. & Mirkin, C. A. Enhancing CRISPR-Cas-mediated detection of nucleic acid and non-nucleic acid targets using enzyme-labeled reporters. J. Am. Chem. Soc. 144, 16310–16315 (2022).
Huang, D., Ni, D. S., Fang, M., Shi, Z. & Xu, Z. Microfluidic ruler-readout and CRISPR Cas12a-responded hydrogel-integrated paper-based analytical devices (μReaCH-PAD) for visible quantitative point-of-care testing of invasive fungi. Anal. Chem. 93, 16965–16973 (2021).
Johnston, M. et al. Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management. Mater. Today 61, 129–138 (2022). This study introduced a CRISPR-powered, amplification-free technology for monitoring viral RNA alongside antibiotic concentrations, offering a sensitive solution for pandemic response.
Tao, X. et al. Sensitive and on-site detection of Staphylococcus aureus based on CRISPR/Cas 13a-assisted chemiluminescence resonance energy transfer. Anal. Chem. 96, 9270–9277 (2024).
Shamsabadi, A., Haghighi, T., Carvalho, S., Frenette, L. C. & Stevens, M. M. The nanozyme revolution: enhancing the performance of medical biosensing platforms. Adv. Mater. 36, 2300184 (2024). This review explored the potential of nanozymes to improve medical biosensing platforms by improving signal amplification and enhancing detection limits.
Broto, M. et al. Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs. Nat. Nanotechnol. 17, 1120–1126 (2022). This study introduced CrisprZyme, a nanozyme-linked immunosorbent assay that enables preamplification-free, quantitative detection of non-coding RNAs in both plate- and paper-based assay formats.
Arshad, F., Abdillah, A. N., Shivanand, P. & Ahmed, M. U. CeO2 nanozyme mediated RPA/CRISPR-Cas12a dual-mode biosensor for detection of invA gene in Salmonella. Biosens. Bioelectron. 247, 115940 (2024).
An, P. et al. CRISPR/Cas12a bio-assay integrated with metal-organic framework based enhanced fluorescent labels for ultrasensitive detection of circulating tumor DNA. Sens. Actuat. B 383, 133623 (2023).
Hong, S. et al. A non-FRET DNA reporter that changes fluorescence colour upon nuclease digestion. Nat. Nanotechnol. 19, 810–817 (2024). This study introduced a low-cost, DNA-templated, Ag-nanocluster-based reporter for nucleic acid detection that changes colour upon CRISPR digestion.
Fu, X. et al. Exploring the trans-cleavage activity of CRISPR/Cas12a on gold nanoparticles for stable and sensitive biosensing. Anal. Chem. 93, 4967–4974 (2021).
Luo, T. et al. Designing a CRISPR/Cas12a- and Au-nanobeacon-based diagnostic biosensor enabling direct, rapid, and sensitive miRNA detection. Anal. Chem. 94, 6566–6573 (2022).
Green, C. M. et al. Quantum dot-based molecular beacons for quantitative detection of nucleic acids with CRISPR/Cas(N) nucleases. ACS Nano 16, 20693–20704 (2022). This study presented fluorescently labelled DNA or RNA hairpins conjugated to ZnS-coated quantum dots that form ratiometric reporters for FRET-based detection of DNA and RNA.
Zhang, Q. et al. SARS-CoV-2 detection using quantum dot fluorescence immunochromatography combined with isothermal amplification and CRISPR/Cas13a. Biosens. Bioelectron. 202, 113978 (2022).
Li, C. Y. et al. A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets. Biosens. Bioelectron. 169, 112650 (2020).
Guan, L. et al. Ultrasensitive miRNA detection based on magnetic upconversion nanoparticle enhancement and CRISPR/Cas13a-driven signal amplification. Anal. Chem. 95, 17708–17715 (2023).
Giesselmann, P. et al. Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing. Nat. Biotechnol. 37, 1478–1481 (2019).
Gilpatrick, T. et al. Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat. Biotechnol. 38, 433–438 (2020).
McDonald, T. L. et al. Cas9 targeted enrichment of mobile elements using nanopore sequencing. Nat. Commun. 12, 3586 (2021).
Liu, M. et al. A label-free photoelectrochemical biosensor based on CRISPR/Cas12a system responsive deoxyribonucleic acid hydrogel and ‘click’ chemistry. ACS Sens. 7, 3153–3160 (2022).
Ban, D. K. et al. A single multiomics transistor for electronic detection of SARS-Cov2 variants antigen and viral rna without amplification. Adv. Mater. Technol. 8, 2201945 (2023).
Wang, H. et al. Unamplified system for sensitive and typing detection of ASFV by the cascade platform that CRISPR-Cas12a combined with graphene field-effect transistor. Biosens. Bioelectron. 240, 115637 (2023).
Balderston, S. et al. Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor. Nat. Biomed. Eng. 5, 713–725 (2021). This study expands on the use of graphene and Cas9-based FET biosensors for rapid, amplification-free detection of single-point mutations in genomic DNA.
Zhang, J. et al. Mxene coupled with CRISPR-Cas12a for analysis of endotoxin and bacteria. Anal. Chem. 93, 4676–4681 (2021).
Duan, H. et al. A CRISPR-Cas12a powered electrochemical sensor based on gold nanoparticles and MXene composite for enhanced nucleic acid detection. Sens. Actuat. B 380, 133342 (2023).
Guo, J., Zhu, Y. & Miao, P. Nano-impact electrochemical biosensing based on a CRISPR-responsive DNA hydrogel. Nano Lett. 23, 11099–11104 (2023).
Ates, H. C. et al. End-to-end design of wearable sensors. Nat. Rev. Mater. 15, 887–907 (2022).
Nguyen, P. Q. et al. Wearable materials with embedded synthetic biology sensors for biomolecule detection. Nat. Biotechnol. 39, 1366–1374 (2021).
Andrews, J. P. M. et al. First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses. Nat. Nanotechnol. 19, 705–714 (2024).
Zargartalebi, H. et al. Active-reset protein sensors enable continuous in vivo monitoring of inflammation. Science 386, 1146–1153 (2024).
Yi, Y. et al. Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection. Nat. Nanotechnol. (2025).
McGenity, C. et al. Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy. npj Digit. Med. 7, 114 (2024).
Li, L. et al. Interactions of bacteria with monolithic lateral silicon nanospikes inside a microfluidic channel. Front. Chem. 7, 483 (2019).
